May-Levin F - Search Results

1

Human breast tumors: a comparison between the biochemical method of measuring estrogen and progesterone receptors and that of an immunohistochemical method.

Lacombe MJ, Delarue JC, Mouriesse H, Contesso G, Friedman S, Sancho-Garnier H, Travagli JP, May-Levin F. Lacombe MJ, et al. Gynecol Oncol. 1989 Feb;32(2):174-9. doi: 10.1016/s0090-8258(89)80029-0. Gynecol Oncol. 1989. PMID: 2910778

2

[Enzymo-immunoassay of progesterone receptors in human breast lesions and tumors. Comparison with a biochemical method].

Delarue JC, Bertin F, May-Levin F, Mouriesse H. Delarue JC, et al. Bull Cancer. 1989;76(3):329-32. Bull Cancer. 1989. PMID: 2660942 French.

3

A new approach allowing an early prognosis in breast cancer: the ratio of estrogen receptor (ER) ligand binding activity to the ER-specific mRNA level.

May E, Mouriesse H, May-Levin F, Contesso G, Delarue JC. May E, et al. Oncogene. 1989 Aug;4(8):1037-42. Oncogene. 1989. PMID: 2761986

4

Estrogen and progesterone receptors in benign breast tumors and lesions: relationship with histological and cytological features.

Giani C, D'Amore E, Delarue JC, Mouriesse H, May-Levin F, Sancho-Garnier H, Breccia M, Contesso G. Giani C, et al. Int J Cancer. 1986 Jan 15;37(1):7-10. doi: 10.1002/ijc.2910370103. Int J Cancer. 1986. PMID: 3000957

5

Epidermal growth factor receptor in human breast cancers: correlation with estrogen and progesterone receptors.

Delarue JC, Friedman S, Mouriesse H, May-Levin F, Sancho-Garnier H, Contesso G. Delarue JC, et al. Breast Cancer Res Treat. 1988 May;11(2):173-8. doi: 10.1007/BF01805841. Breast Cancer Res Treat. 1988. PMID: 3401606

6

[Estrogen receptors in cancer of the breast. Comparison of 2 methods].

Delarue JC, Mouriesse H, Contesso G, Bonnay M, May-Levin F, Sancho-Garnier H, Travagli JP, Lacombe MJ. Delarue JC, et al. Ann Biol Clin (Paris). 1986;44(6):629-33. Ann Biol Clin (Paris). 1986. PMID: 3548499 French.

7

Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.

Delarue JC, May-Levin F, Mouriesse H, Contesso G, Sancho-Garnier H. Delarue JC, et al. Br J Cancer. 1981 Dec;44(6):911-6. doi: 10.1038/bjc.1981.291. Br J Cancer. 1981. PMID: 7326200 Free PMC article.

8

Combined overexpression of c-erbB-2 protein and epidermal growth factor receptor (EGF-R) could be predictive of early and long-term outcome in human breast cancer: a pilot study.

Delarue JC, Terrier P, Terrier-Lacombe MJ, Mouriesse H, Gotteland M, May-Levin F. Delarue JC, et al. Among authors: may levin f. Bull Cancer. 1994 Dec;81(12):1067-77. Bull Cancer. 1994. PMID: 7742595

9

Estrogen receptors (ER) in human breast cancer. The significance of a new prognostic factor based on both ER protein and ER mRNA contents.

Gotteland M, May E, May-Levin F, Contesso G, Delarue JC, Mouriesse H. Gotteland M, et al. Among authors: may levin f. Cancer. 1994 Aug 1;74(3):864-71. doi: 10.1002/1097-0142(19940801)74:3<864::aid-cncr2820740312>3.0.co;2-n. Cancer. 1994. PMID: 7913659

10

Is the negative prognostic value of high oestrogen receptor (ER) levels in postmenopausal breast cancer patients due to a modified ER gene product?

Sancho-Garnier H, Delarue JC, Mouriesse H, Contesso G, May-Levin F, Gotteland M, May E. Sancho-Garnier H, et al. Among authors: may levin f. Eur J Cancer. 1995 Oct;31A(11):1851-5. doi: 10.1016/0959-8049(95)00387-x. Eur J Cancer. 1995. PMID: 8541112

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

54 results

Search Page

Filters